Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.93 |
| ▸ | AKR1B10 | O60218 | 7/20 | 0.79 |
| ▸ | AKR1B1 | P15121 | 7/20 | 0.79 |
| ▸ | CA12 | O43570 | 3/20 | 0.79 |
| ▸ | CA4 | P22748 | 3/20 | 0.79 |
| ▸ | CA6 | P23280 | 3/20 | 0.79 |
| ▸ | CA5A | P35218 | 3/20 | 0.79 |
| ▸ | CA7 | P43166 | 3/20 | 0.79 |
| ▸ | CA9 | Q16790 | 3/20 | 0.79 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.79 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.79 |
| ▸ | TTR | P02766 | 1/20 | 0.66 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.64 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | APP | P05067 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MET | P08581 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzyl Cinnamate SCHEMBL43213 | 0.96 | LMNA (1.00) | LMNAAKR1B10AKR1B1CA12CA4 | |
| Benzyl Cinnamate SCHEMBL1871854 | 0.96 | LMNA (1.00) | LMNAAKR1B10AKR1B1CA12CA4 | |
| Benzyl Cinnamate SCHEMBL901152 | 0.96 | LMNA (1.00) | LMNAAKR1B10AKR1B1CA12CA4 | |
| Benzyl Cinnamate SCHEMBL43212 | 0.96 | LMNA (1.00) | LMNAAKR1B10AKR1B1CA12CA4 | |
| SCHEMBL22510990 | 0.95 | AKR1B10 (0.88) | LMNAAKR1B10AKR1B1CA12CA4 | |
| Benzyl Cinnamate SCHEMBL28028350 | 0.93 | LMNA (0.93) | LMNAAKR1B10AKR1B1CA12CA4 | |
| SCHEMBL13552179 | 0.93 | LMNA (0.93) | LMNAAKR1B10AKR1B1CA12CA4 | |
| Benzyl Cinnamate SCHEMBL30513717 | 0.92 | LMNA (0.90) | LMNAAKR1B10AKR1B1CA12CA4 | |
| SCHEMBL8377990 | 0.91 | LMNA (0.77) | LMNAAKR1B10AKR1B1CA12CA4 | |
| SCHEMBL8377988 | 0.91 | LMNA (0.77) | LMNAAKR1B10AKR1B1CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968452-B2 | Phase change inks containing crystalline trans-cinnamic diesters and amorphous isosorbide oligomers | XEROX CORPORATION (US) | 2015-03-03 | — | — | US | disclosed |
| US-8968452-B2 | Phase change inks containing crystalline trans-cinnamic diesters and amorphous isosorbide oligomers | XEROX CORPORATION (US) | 2015-03-03 | — | — | US | disclosed |
| US-8952191-B2 | Ester resin compositions | XEROX CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| US-8952191-B2 | Ester resin compositions | XEROX CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| US-8936359-B2 | Ink compositions incorporating ester resins | XEROX CORPORATION (US) | 2015-01-20 | — | — | US | disclosed |
| US-8936359-B2 | Ink compositions incorporating ester resins | XEROX CORPORATION (US) | 2015-01-20 | — | — | US | disclosed |
| US-8906150-B2 | Phase change inks containing crystalline trans-cinnamic diesters and polyterpene resins | XEROX CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-8906150-B2 | Phase change inks containing crystalline trans-cinnamic diesters and polyterpene resins | XEROX CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-8778069-B2 | Phase change inks containing oligomeric rosin esters | XEROX CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8778069-B2 | Phase change inks containing oligomeric rosin esters | XEROX CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-20140139591-A1 | INK COMPOSITIONS INCORPORATING ESTER RESINS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140137767-A1 | Phase Change Inks Containing Oligomeric Rosin Esters | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140137767-A1 | Phase Change Inks Containing Oligomeric Rosin Esters | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140139591-A1 | INK COMPOSITIONS INCORPORATING ESTER RESINS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140142335-A1 | ESTER RESIN COMPOSITIONS | XEROX CORPORATION (US) | 2014-05-22 | — | — | US | disclosed |
| US-20130131226-A1 | Phase Change Inks Containing Crystalline Trans-Cinnamic Diesters and Polyterpene Resins | XEROX CORPORATION (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130131226-A1 | Phase Change Inks Containing Crystalline Trans-Cinnamic Diesters and Polyterpene Resins | XEROX CORPORATION (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130032056-A1 | Phase Change Inks Containing Crystalline Trans-Cinnamic Diesters and Amorphous Isosorbide Oligomers | XEROX CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| US-20130032056-A1 | Phase Change Inks Containing Crystalline Trans-Cinnamic Diesters and Amorphous Isosorbide Oligomers | XEROX CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| WO-2012149604-A1 | BIS-THYMINE DERIVATIVES AND PHOTO-REVERSIBLE POLYMERS THEREOF | MONASH UNIVERSITY (AU) | 2012-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142335-A1 | ESTER RESIN COMPOSITIONS | ELL, ELOB, ELOC | LMNA 2207/4885AKR1B10 1565/4885AKR1B1 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.